Seppo O. Pyrhonen

Turku, Finland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

Long-term Outcome With Prolonged Use of Interferon-alpha Administered Intermittently for Metastatic Renal Cell Carcinoma: A Phase II Study.

Long-term Outcome With Prolonged Use of Interferon-alpha Administered Intermittently for Metastatic Renal Cell Carcinoma: A Phase II Study.

Journal: Anticancer research
Published: February 26, 2023

Cytoplasmic E-Cadherin Expression Is Associated With Higher Tumour Level of VEGFA, Lower Response Rate to Irinotecan-based Treatment and Poorer Prognosis in Patients With Metastatic Colorectal Cancer.

Cytoplasmic E-Cadherin Expression Is Associated With Higher Tumour Level of VEGFA, Lower Response Rate to Irinotecan-based Treatment and Poorer Prognosis in Patients With Metastatic Colorectal Cancer.

Journal: Anticancer research
Published: January 22, 2019

Long-term Survival of Stage IV Melanoma Patients Treated with BOLD Combination Chemotherapy and Intermediate-dose Subcutaneous Interferon-alpha.

Long-term Survival of Stage IV Melanoma Patients Treated with BOLD Combination Chemotherapy and Intermediate-dose Subcutaneous Interferon-alpha.

Journal: Anticancer research
Published: October 02, 2018

Patients with hMLH1 or/and hMSH2-deficient Metastatic Colorectal Cancer Are Associated with Reduced Levels of Vascular Endothelial Growth Factor-1 Expression and Higher Response Rate to Irinotecan-based Regimen.

Patients with hMLH1 or/and hMSH2-deficient Metastatic Colorectal Cancer Are Associated with Reduced Levels of Vascular Endothelial Growth Factor-1 Expression and Higher Response Rate to Irinotecan-based Regimen.

Journal: Anticancer research
Published: September 21, 2018

The effect of vascular endothelial growth factor-1 expression on survival of advanced colorectal cancer patients.

The effect of vascular endothelial growth factor-1 expression on survival of advanced colorectal cancer patients.

Journal: The Libyan journal of medicine
Published: March 02, 2017

Neurofibromin Expression is Associated with Aggressive Disease and Poor Outcome in Colorectal Carcinoma.

Neurofibromin Expression is Associated with Aggressive Disease and Poor Outcome in Colorectal Carcinoma.

Journal: Anticancer research
Published: August 12, 2016

Quality of life with biweekly docetaxel and capecitabine in advanced gastro-oesophageal cancer.

Quality of life with biweekly docetaxel and capecitabine in advanced gastro-oesophageal cancer.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: June 15, 2016

Randomized, controlled trial of the effect of e-feedback on knowledge about radiotherapy of breast cancer patients in Finland.

Randomized, controlled trial of the effect of e-feedback on knowledge about radiotherapy of breast cancer patients in Finland.

Journal: Nursing & health sciences
Published: May 27, 2014

Benefit of adjuvant interferon alfa-2b (IFN-α) therapy in melanoma patients with high serum MMP-8 levels.

Benefit of adjuvant interferon alfa-2b (IFN-α) therapy in melanoma patients with high serum MMP-8 levels.

Journal: Cancer immunology, immunotherapy : CII
Published: March 14, 2014

Psychosocial outcomes of e-feedback of radiotherapy for breast cancer patients: a randomized controlled trial.

Psychosocial outcomes of e-feedback of radiotherapy for breast cancer patients: a randomized controlled trial.

Journal: Psycho-oncology
Published: March 10, 2014

Toremifene in the treatment of breast cancer.

Toremifene in the treatment of breast cancer.

Journal: World journal of clinical oncology
Published: December 18, 2013

High cyclooxygenase-2 expression is associated with advanced stages in colorectal cancer.

High cyclooxygenase-2 expression is associated with advanced stages in colorectal cancer.

Journal: Anticancer research
Published: July 31, 2013
Showing 1-12 of 27

Last Updated: 09/26/2026